Qualified Scientists and team leaders to support development of complex generics

At Reyanvi Healthcare, we understand client's need to develop robust, bioequivalent formulations as per regulatory requirements.

1. Oral Solid Dosage Forms (IR, SR, MR, DR, Palletisation, HME etc.)

   1) Immediate Release (IR) Tablets
   2) Delayed Release (DR) Tablets
   3) Extended/Prolonged/ Controlled Release (ER/PR/CR) Tablets
   4) Orally Disintegrating Tablets (ODT)
   5) Bi-layered Tablets
   6) Chewable Tablets
   7) Sublingual Tablets
   8) Granules/powder filled into hard gelatine capsules
   9) IR, ER, DR and PR Pellets filled into hard gelatine capsules
   10) Mini tablets filled into hard gelatine capsules
   
2. Liquid Orals (Syrups, Suspensions, Emulsions, Lotions, Solutions)
3. Product based on HME (Hot Melt Extrusion)
4. Semi Solids

   1) Gels
   2) Creams
   3) Ointments
5. Dry Powder Suspensions
6. Onco products
7. Ophthalmic, Otic products
8. Injectable
9. Reverse engineering for all kind of formulations
10. Q1,Q2,Q3 estimation for all kind of dosage forms
11. Product development report (As per QBD approach)
12. Formulation development as per QBD (using DOE) for NME’s, generics, 505B2, hybrid application, differentiated formulation & OTC’s
13. Competitive generic therapy (CGT)